Literature DB >> 14747304

Messenger RNA transcripts of the hepatocyte nuclear factor-1alpha gene containing premature termination codons are subject to nonsense-mediated decay.

Lorna W Harries1, Andrew T Hattersley, Sian Ellard.   

Abstract

Mutations in the hepatocyte nuclear factor-1alpha (HNF-1a) gene cause maturity-onset diabetes of the young (MODY). Approximately 30% of these mutations generate mRNA transcripts harboring premature termination codons (PTCs). Degradation of such transcripts by the nonsense-mediated decay (NMD) pathway has been reported for many genes. To determine whether PTC mutant transcripts of the HNF-1alpha gene elicit NMD, we have developed a novel quantitative RT-PCR assay. We performed quantification of ectopically expressed mutant transcripts relative to normal transcripts in lymphoblastoid cell lines using a coding single nucleotide polymorphism (cSNP) as a marker. The nonsense mutations R171X, I414G415ATCG-->CCA, and P291fsinsC showed reduced mutant mRNA expression to 40% (P = 0.009), <0.01% (P </= 0.0001), and 6% (P = 0.001), respectively, of the normal allele. Transcript levels were restored using the translation inhibitor cycloheximide, indicating that the instability arises from NMD. The missense mutations G207D and R229P did not show NMD although R229P exhibited moderate RNA instability. This study provides the first evidence that HNF-1alpha PTC mutations may be subject to NMD. Mutations that result in significant reduction of protein levels due to NMD will not have dominant-negative activity in vivo. Haploinsufficiency is therefore likely to be the most important mutational mechanism of HNF-1alpha mutations causing MODY.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747304     DOI: 10.2337/diabetes.53.2.500

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  18 in total

1.  The position of premature termination codons in the hepatocyte nuclear factor -1 beta gene determines susceptibility to nonsense-mediated decay.

Authors:  L W Harries; Coralie Bingham; Christine Bellanne-Chantelot; A T Hattersley; Sian Ellard
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

2.  Expression of mutant JAGGED1 alleles in patients with Alagille syndrome.

Authors:  Julie Boyer; Cécile Crosnier; Catherine Driancourt; Nicole Raynaud; Marie Gonzales; Michelle Hadchouel; Michèle Meunier-Rotival
Journal:  Hum Genet       Date:  2005-03-17       Impact factor: 4.132

3.  Functional analyses of the mutation nt-128 T→G in the hepatocyte nuclear factor-1α promoter region in Chinese diabetes pedigrees.

Authors:  Q Fang; S Chen; Y Wang; S Jiang; R Zhang; C Hu; C Wang; F Liu; K Xiang; W Jia
Journal:  Diabet Med       Date:  2012-11       Impact factor: 4.359

4.  Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage.

Authors:  Emmanuelle Jeannot; Lucille Mellottee; Paulette Bioulac-Sage; Charles Balabaud; Jean-Yves Scoazec; Jeanne Tran Van Nhieu; Yannick Bacq; Sophie Michalak; David Buob; Pierre Laurent-Puig; Ivan Rusyn; Jessica Zucman-Rossi
Journal:  Diabetes       Date:  2010-04-14       Impact factor: 9.461

5.  Dominant-negative mutant hepatocyte nuclear factor 1alpha induces diabetes in transgenic-cloned pigs.

Authors:  Kazuhiro Umeyama; Masahito Watanabe; Hitoshi Saito; Mayuko Kurome; Sadaaki Tohi; Hitomi Matsunari; Keizaburo Miki; Hiroshi Nagashima
Journal:  Transgenic Res       Date:  2009-04-09       Impact factor: 2.788

6.  RNA processing and mRNA surveillance in monogenic diabetes.

Authors:  Jonathan M Locke; Lorna W Harries
Journal:  Gene Regul Syst Bio       Date:  2008-05-21

Review 7.  100 YEARS OF INSULIN: A brief history of diabetes genetics: insights for pancreatic beta-cell development and function.

Authors:  Jennifer M Ikle; Anna L Gloyn
Journal:  J Endocrinol       Date:  2021-07-22       Impact factor: 4.669

8.  Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young.

Authors:  S Ellard; C Bellanné-Chantelot; A T Hattersley
Journal:  Diabetologia       Date:  2008-02-23       Impact factor: 10.122

9.  Using microarrays to facilitate positional cloning: identification of tomosyn as an inhibitor of neurosecretion.

Authors:  Michael Dybbs; John Ngai; Joshua M Kaplan
Journal:  PLoS Genet       Date:  2005-07-25       Impact factor: 5.917

10.  Diabetes susceptibility in the Canadian Oji-Cree population is moderated by abnormal mRNA processing of HNF1A G319S transcripts.

Authors:  Lorna W Harries; Melissa J Sloman; Elizabeth A C Sellers; Andrew T Hattersley; Sian Ellard
Journal:  Diabetes       Date:  2008-07       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.